•

ACUTAAS CHEMICALS LIMITED (ACUTAAS) Share Price, Financials & Peer Comparison - StoxVise

ACUTAASNSE🇮🇳 India Bluechip Statutory NSE/BSE 15m Delayed

ACUTAAS CHEMICALS LIMITED

Healthcare•Large Cap

₹3,786.60

+₹15.80(+0.42%)Today

Website NSE BSE Google Finance

ACUTAAS Technical Chart

Loading Candlesticks...

Bullish Candle Bearish Candle

— MA(20)— MA(50)

Scroll / pinch to zoom • Drag to pan

Highcharts & Miro Fundamentals VisualizerFY 2026 Filings

Where Does ACUTAAS CHEMICALS LIMITED's Money Flow?

Clear visual breakdown: for every ₹100 earned, see how much flows to salaries, operating costs, government taxes, EPS profit, and your share.

Profit Conversion

₹26.8/ ₹100

High profit margin business

Human Capital & Talent

₹12.0/ ₹100

Workforce salaries, engineers & talent

Earnings Per Share (EPS)

₹43.37/ share

Annual profit generated per stock unit

Shareholder Payout

₹4.9/ ₹100

Direct cash dividends & buybacks

Multi-Stage Money Stream (Sankey Flow)

Hover or drag nodes to inspect connections and money volumeMode: Every ₹100 Company Sales

Revenue

Materials / Production

Human Capital (Talent)

Government Taxes

Net Profit / EPS

Dividends & Reinvestment

Topline Money Inflow100.0%

Gross Commercial Revenue

₹100.00per ₹100 sales

For every ₹100 collected by ACUTAAS CHEMICALS LIMITED from customers and clients globally.

Raw Materials, Energy & Inventory46.5%

Direct Production & Materials (COGS)

₹46.46per ₹100 sales

Direct physical costs required to produce the company's products, chip fabrication, server components, or merchandise.

Salaries, Benefits, R&D & Talent12.0%

Human Capital & Engineering Workforce

₹12.00per ₹100 sales

Compensation paid to software engineers, technicians, designers, operators, and staff driving the business forward.

Cloud Servers, Sales, Marketing & Legal16.5%

Operating, Tech & Administrative (SG&A)

₹16.46per ₹100 sales

Essential business operations including data center infrastructure, global marketing, compliance, and office facilities.

Interest to Bank Lenders & Bondholders0.2%

Debt Servicing & Financing Costs

₹0.21per ₹100 sales

Cost of borrowed capital. Lower interest outlays indicate low debt dependency and strong financial solvency.

Direct Corporate Tax Paid to State9.5%

Government Corporate Taxes

₹9.51per ₹100 sales

Statutory income taxes contributed to national infrastructure, roads, defense, and public governance.

Pure Profit Belongs to Shareholders26.8%

Net Bottom-Line Profit (EPS Engine)

₹26.81per ₹100 sales

The ultimate earnings of the company. This forms your Diluted EPS (₹43.37/share) and belongs entirely to equity owners.

Cash Deposited to Investor Bank Accounts0.9%

Direct Cash Dividends

₹0.92per ₹100 sales

Actual liquid profits credited directly into your brokerage or bank account as passive dividend cash flow.

Reduces Share Count to Elevate EPS4.0%

Share Repurchases (Buybacks)

₹4.02per ₹100 sales

The company buys its own shares off the market and retires them, making your remaining shares represent a larger slice of future profits.

Reinvested in New Factories, AI & Tech24.7%

Capital Expenditure (Growth CapEx)

₹24.68per ₹100 sales

Long-term capital assets purchased: next-gen server clusters, robotics, retail stores, or production assembly lines.

Retained Earnings on Balance Sheet21.9%

Treasury Reserves & War Chest

₹21.87per ₹100 sales

Cash reserves stored in bank deposits, treasuries, and safe liquid investments to withstand crises and fund sudden strategic acquisitions.

Shareholder Capital Simulator: Where Does Your Investment Go?

Select or type any investment amount to see how much commercial activity and earnings your money commands in ACUTAAS CHEMICALS LIMITED.

Your Investment:₹50,000 (~13.2 shares at ₹3786.6/share)

Annual Revenue

₹2,136

Generated by your capital

Human Capital

₹256

Engineers & staff salaries

Taxes Paid

₹203

Public infrastructure

Your Net Earnings

₹573

Annual profit earned by you (1.1% yield)

Cash Dividend

₹20

Direct cash to your bank

Growth CapEx

₹527

Reinvested in tech & expansion

How to read this flow diagram as an investor:Revenue represents gross sales (₹100). Before any profit can reach you, the company must first pay suppliers (COGS), its workforce & engineers (Human Capital), rent & technology (SG&A), lenders (Interest), and the government (Taxes). What remains is Net Profit (Diluted EPS). Healthy companies divide this profit between Cash Dividends, Share Buybacks (retiring shares to boost your percentage ownership), and CapEx Reinvestment to build new capacity for future years.

Key Fundamentals & Ratios

Real-Time Screener Matrix

Market Cap

₹31,001 Cr

Large Cap

Current Price

₹3,786.60

+0.42% today

52W High / Low

₹4045.3 / ₹1570

Past 52 weeks historical

Stock P/E

70.9

Forward: 48.1

Book Value

₹226.90

Price to Book: 16.69x

Dividend Yield

0.07%

Annualised distribution

Return on Equity (ROE)

26.1%

Shareholder returns efficiency

1-Year Return

+113.64%

52W change percent

52W Low: ₹1,570.00Current price sits at 90% of 52W range52W High: ₹4,045.30

About ACUTAAS CHEMICALS LIMITED

Healthcare & Pharma

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

TTM Revenue₹1,593 Cr

Net Profit Margin27.6%

Operating Margin37.4%

EPS (Trailing)₹53.42

Peer Comparison

Comparing ACUTAAS CHEMICALS LIMITED with leading competitors in Healthcare & Pharma (Indian Market)

#	Company Name	CMP	1D %	P/E	Market Cap	Div Yield	1Y Return	52W Range	Book Value
1	ANTHEM BIOSCIENCES LTD(ANTHEM)	₹915.55	+0.22%	84.8	₹51,594 Cr	0.22%	+31.15%	579.15 – 977.55	₹58.2
2	ACUTAAS CHEMICALS LIMITEDCurrent	₹3,786.60	+0.42%	70.9	₹31,001 Cr	0.07%	+113.64%	1570 – 4045.3	₹226.9
3	DR AGARWALS HEALTH CARE L(AGARWALEYE)	₹516.35	+0.91%	94.9	₹16,371 Cr	0.00%	+1.58%	401 – 567.75	₹67.4
4	ADVANCED ENZYME TECH LTD(ADVENZYMES)	₹280.30	-1.41%	18.1	₹3,023 Cr	0.48%	-8.41%	246.8 – 419	₹149.8
5	3B BLACKBIO DX LTD.(3BBLACKBIO)	₹1,284.20	-1.90%	19.1	₹1,102 Cr	0.39%	+13.99%	1099.5 – 1740	₹388.4
6	ANUH PHARMA LIMITED(ANUHPHR)	₹81.55	-0.74%	18.4	₹817 Cr	1.84%	-4.38%	67 – 99.5	₹36.0
7	AAREY DRUGS & PHARM LTD(AAREYDRUGS)	₹107.72	-1.52%	72.3	₹343 Cr	0.00%	+12.46%	50.31 – 114.8	₹52.9

Data Provenance & Regulatory DisclosureSource: NSE/BSE Statutory Filings

Quotes are delayed by at least 15 minutes. Financial metrics and disclosures are cross-referenced with periodic statutory disclosures from the National Stock Exchange of India (NSE) and BSE India. This content is provided strictly for educational and portfolio analytics purposes, and does not constitute investment advice or Buy/Sell recommendations.